Side-by-side financials for AVTX and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AVTX | NVS |
|---|---|---|
| Market cap | - | $292.08 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $59.00K | - |
| Net income (latest FY) | -$78.26M | - |
| Net margin | -132642.4% | - |
| SEC filings | 997 | 947 |
Full pages: Avalo Therapeutics, Inc. and Novartis AG, or browse the full rankings.